Acta Med. 2022, 65: 125-132
https://doi.org/10.14712/18059694.2023.2
Primary Duodenal Melanoma: Challenges in Diagnosis and Management of a Rare Entity
References
1. Am J Gastroenterol 1996; 91: 1001–6.
AM, Albahra M, Nzeako UC, Sobin LH. Malignant melanomas in the small intestine: a study of 103 patients.
2. J Clin Gastroenterol 2000; 30: 4414.
< SH, Madison JF, Hwu WJ, Bayar S, Salem RR. Colonic melanoma, primary or regressed primary. https://doi.org/10.1097/00004836-200006000-00019>
3. Lancet Oncol 2009; 10: 516–21.
< M, Bataille V, Krivokapic Z. Melanoma of the small intestine. https://doi.org/10.1016/S1470-2045(09)70036-1>
4. Am J Gastroenterol 1999; 94: 3427–33.
< D, Abraham S, Furth EE, Kochman ML. Melanoma in the gastrointestinal tract. https://doi.org/10.1111/j.1572-0241.1999.01604.x>
5. Am Surg 2016; 82: 1–5.
< DD, Deutsch GB, Foshag LJ, Lee JH, Sim MS, Faries MB. Evolving therapeutic strategies in mucosal melanoma have not improved survival over five decades. https://doi.org/10.1177/000313481608200102>
6. 2020; 12: e9483.
RJ, Sohal S, Wazir A, Benjamin S. Mucosal melanoma: a rare entity and review of the literature. Cureus
7. Cancers 2020; 12.
P, Czarnecka AM, Indini A, et al. Multimodal treatment of advanced mucosal melanoma in the era of modern immunotherapy.
8. J Gastrointest Surg 2008; 12: 731–8.
< MC, Perez EA, Molina MA, et al. Defining the role of surgery for primary gastrointestinal tract melanoma. https://doi.org/10.1007/s11605-007-0417-3>
9. Caspian J Intern Med 2018; 9: 312–5.
K, Gharib M, Jafarian AH, Saburi A, Javadinia SA. Primary duodenal malignant melanoma: A case report.
10. Diagn Pathol 2012; 7: 74.
< H, Fan Q, Wang Z, et al. Primary malignant melanoma of the duodenum without visible melanin pigment: a mimicker of lymphoma or carcinoma. https://doi.org/10.1186/1746-1596-7-74>
<PubMed>
11. Cancer 1977; 39: 164–71.
< RL, Rosen PP, Thaler H. Nevus cell aggregates associated with lymph nodes: estimated frequency and clinical significance. https://doi.org/10.1002/1097-0142(197701)39:1<164::AID-CNCR2820390127>3.0.CO;2-T>
12. Cancer 1967; 20: 632–49.
< Y. Melanocytic and nevocytic malignant melanomas. Cellular and subcellular differentiation. https://doi.org/10.1002/1097-0142(1967)20:5<632::AID-CNCR2820200510>3.0.CO;2-7>
13. J Surg Oncol 1978; 10: 283–8.
< MM, Ariel I, Behar AJ. Primary malignant melanoma of the small intestine and the APUD cell concept. https://doi.org/10.1002/jso.2930100402>
14. J Am Acad Dermatol 1999; 41: 1042–4.
< DL, Lowe L, Chang AE, Carson E, Johnson TM. Do primary small intestinal melanomas exist? Report of a case. https://doi.org/10.1016/S0190-9622(99)70273-2>
15. World J Gastroenterol 2007; 13: 4027–9.
< A, Genetzakis M, Lagoudianakis E, et al. Malignant gastrointestinal melanomas of unknown origin: should it be considered primary? https://doi.org/10.3748/wjg.v13.i29.4027>
<PubMed>
16. Pathology 1975; 7: 91–9.
< VJ. Spontaneous regression of melanoma. https://doi.org/10.3109/00313027509092702>
17. Ann Surg Oncol 1999; 6: 155–60.
< AC, Buell JF, Venzon D, Baker AR, Libutti SK. Management of symptomatic malignant melanoma of the gastrointestinal tract. https://doi.org/10.1007/s10434-999-0155-8>
18. Ann R Coll Surg Engl 2017; 99: e131-e134.
< R, Singh AN, Dash NR, Madhusudhan KS, Das P. Primary giant aggressive amelanotic duodenal melanoma. https://doi.org/10.1308/rcsann.2016.0323>
<PubMed>
19. Clin J Gastroenterol 2020; 13: 532–53.
< RCT, do Prado Silveira S, Dos Santos ES, de Meirelles LR. Long-term survival after surgical treatment followed by adjuvant systemic therapy for primary duodenal melanoma. https://doi.org/10.1007/s12328-020-01112-9>
20. J Gastrointest Cancer 2013; 45: 242–3.
< S, Ekiz, F, Başar, O. A rare cause of upper gastrointestinal bleeding in an elderly patient: primary duodenal malignant melanoma. https://doi.org/10.1007/s12029-013-9565-8>
21. Indian J Nucl Med 2015; 30: 89–90.
S, Sharma P, Karunanithi S, Bal C, Kumar R. (18)F-FDG PET/CT imaging in a seldom case of primary malignant melanoma of duodenum.
22. Histopathology 2002; 41: 562–3.
< A, Lombard-Bohas C, Saurin JC, Ponchon T, Partensky C, Scoazec JY. Malignant melanoma presenting as an ampullary tumour. https://doi.org/10.1046/j.1365-2559.2002.01457_3.x>
23. Int J Clin Exp Pathol 2012; 5: 739–53.
M, Vlajkovic S, Jovanovic P, Stefanovic V. Primary mucosal melanomas: a comprehensive review.
24. Eur J Surg Oncol 1992; 18: 307–12.
M, Inbar M, Chaitchik S, et al. Malignant melanoma of the mucous membranes.
25. J Am Coll Surg 1994; 179: 561–6.
CM, Chmiel JS, Henson DE, Winchester DP. Patient characteristics, methods of diagnosis, and treatment of mucous membrane melanoma in the United States of America.
26. Surg Today 2002; 32: 831–3.
< KS, Pavlidis TE, Papaziogas BT, Papaziogas TB. Primary malignant melanoma of the small intestine: report of a case. https://doi.org/10.1007/s005950200161>
27. Gastroenterol Clin Biol 2010; 34: 85–7.
< F, Bouzaidi S, Mouelhi L, et al. Diffuse primary malignant melanoma of the upper gastrointestinal tract. https://doi.org/10.1016/j.gcb.2009.05.016>
28. Clin Nucl Med 2020; 45: 164–7.
< Y, Fan QP, Tian R, Su MG. Gastric 99mTc-methylene diphosphonate accumulation in a patient with primary upper gastrointestinal tract melanoma. https://doi.org/10.1097/RLU.0000000000002855>
29. Clin J Gastroenterol 2013; 6: 211–6.
< T, Fujisaki J, Hirasawa T, et al. Primary amelanotic malignant melanoma of the small intestine diagnosed by esophagogastroduodenoscopy before surgical resection. https://doi.org/10.1007/s12328-013-0380-3>
<PubMed>
30. Am J Gastroenterol 2001; 96: 2392–400.
< GN, Maglinte DD, McLarney JH, Rex D, Kelvin FM. Malignant melanoma: patterns of metastasis to the small bowel, reliability of imaging studies, and clinical relevance. https://doi.org/10.1016/S0002-9270(01)02604-1>
31. Hepatobiliary Pancreat Dis Int 2013; 12: 106–8.
< A, Glavina Durdov M, Stipic R, Karaman I. Melanoma in the ampulla of Vater. https://doi.org/10.1016/S1499-3872(13)60016-8>
32. South Med J 2008; 101: 836–9.
< DP, Apostolaki K, Gontikakis E, et al. Primary malignant melanoma of the duodenum: aggressive management and long-term survival of an unusual oncologic entity. https://doi.org/10.1097/SMJ.0b013e31817dfd75>
33. Melanoma Res 2001; 11: 297–301.
< R, Mandelkern M. FDG-PET in the detection of gastrointestinal metastases in melanoma. https://doi.org/10.1097/00008390-200106000-00012>
34. Am J Surg 1970; 120: 425–31.
< AJ. Malignant melanoma of the skin of the head and neck. An analysis of 405 cases. https://doi.org/10.1016/S0002-9610(70)80001-0>
35. Clin Cancer Res 2013; 19: 4488–98.
< B, Si L, Cui C, et al. Phase II randomized trial comparing high-dose IFN-alpha2b with temozolomide plus cisplatin as systemic adjuvant therapy for resected mucosal melanoma. https://doi.org/10.1158/1078-0432.CCR-13-0739>
36. J Surg Oncol 2011; 104: 425–9.
< O, Boasberg PD, Rosenthal K, O’Day SJ. Systemic treatment of metastatic melanoma: new approaches. https://doi.org/10.1002/jso.22034>
37. Surg Oncol Clin N Am 2019; 28: 403–18.
< LD, Sarnaik AA, Khushalani NI, Sondak VK. Current immunotherapy practices in melanoma. https://doi.org/10.1016/j.soc.2019.02.001>
38. Crit Rev Oncol Hematol 2017; 112: 136–52.
< PA, Accorona R, Botti G, et al. Mucosal melanoma of the head and neck. https://doi.org/10.1016/j.critrevonc.2017.01.019>
39. Lab Invest 2017; 97: 1063–71.
< GJ, Cottrell TR, Lilo M, et al. Melanoma subtypes demonstrate distinct PD-L1 expression profiles. https://doi.org/10.1038/labinvest.2017.64>
<PubMed>
40. J Clin Oncol 2017; 35: 226–35.
< SP, Larkin J, Sosman JA, et al. Efficacy and safety of nivolumab alone or in combination with ipilimumab in patients with mucosal melanoma: a pooled analysis. https://doi.org/10.1200/JCO.2016.67.9258>
<PubMed>
41. Clin Cancer Res 2020; 26: 3193–201.
< MA, Knox SJ, Goldman DA, et al. A prospective, phase 1 trial of nivolumab, ipilimumab, and radiotherapy in patients with advanced melanoma. https://doi.org/10.1158/1078-0432.CCR-19-3936>
<PubMed>
42. J Am Acad Dermatol 2014; 71: 366–75.
< JD, Bray J, Cohen YK, et al. Update on primary mucosal melanoma. https://doi.org/10.1016/j.jaad.2014.03.031>
43. Modern Pathol 2018; 31: 24–38.
< L, Lopez-Beltran A, Massari F, MacLennan GT, Montironi R. Molecular testing for BRAF mutations to inform melanoma treatment decisions: a move toward precision medicine. https://doi.org/10.1038/modpathol.2017.104>
<PubMed>
44. Chin Clin Oncol 2014; 3: 35.
KB, Alrwas A. Treatment of KIT-mutated metastatic mucosal melanoma.
45. Pigment Cell Melanoma Res 2021; 34: 44–58.
< GM, Rebecca VW. Emerging strategies to treat rare and intractable subtypes of melanoma. https://doi.org/10.1111/pcmr.12880>
<PubMed>
46. Oncology 2017; 3: e23–e32.
BA, Stewart LA, Horowitz DP, Carvajal RD. Mucosal Melanoma: New insights and therapeutic options for a unique and aggressive disease.
47. Mol Clin Oncol 2014; 2: 233–6.
< G, Tang X, He J, Ren H. Intestinal obstruction due to primary intestinal melanoma in a patient with a history of rectal cancer resectioning: a case report. https://doi.org/10.3892/mco.2013.217>
<PubMed>